Who are Definium Therapeutics, Inc.'s main suppliers?

Definium Therapeutics, Inc. (DFTX) key suppliers include: CONTRACT-MANUFACTURING-ORGANIZATIONS, CONTRACT-RESEARCH-ORGANIZATIONS, THIRD-PARTIES, ORANY, ORANY and 2 more. View the full supplier network at chainsifter.com/chain/DFTX.

Who are Definium Therapeutics, Inc.'s major customers?

Definium Therapeutics, Inc. (DFTX) key customers include: ORANY, ORANY, Tonix Pharmaceuticals Holding Corp., BROADWAY-GOLD-MINING-LTD, EMERGING-GROWTH-COMPANY and 2 more. View the full customer network at chainsifter.com/chain/DFTX.

What sector is Definium Therapeutics, Inc. in?

Definium Therapeutics, Inc. (DFTX) operates in the general sector. ChainSifter tracks its verified supply chain relationships including suppliers, customers, and strategic partners.

Definium Therapeutics, Inc. Suppliers, Customers & Supply Chain (DFTX)

7Suppliers

7Customers

2Debt Items

20Related Chains

Source-Backed Evidence Depth

Definium Therapeutics, Inc. (DFTX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.

17Total relationships

4Distinct source URLs

6High confidence

0.751Average confidence

2026-10-28Latest database update

ChainSifter does not infer unreported suppliers, customers, ownership, acquisitions, debt exposure, revenue dependency, or future supply-chain events on this public page.

Definium Therapeutics, Inc. Suppliers

Ticker	Name	Confidence	Evidence
CONTRACT-MANUFACTURING-ORGANIZATIONS	CONTRACT-MANUFACTURING-ORGANIZATIONS	90%	the cost of manufacturing products for use in our preclinical studies and clinical trials, including payments to contract manufacturing organizations and consultants
CONTRACT-RESEARCH-ORGANIZATIONS	CONTRACT-RESEARCH-ORGANIZATIONS	90%	payments to third parties in connection with the clinical development of our product candidates, including licensing fees and fees to contract research organizations and consultants
THIRD-PARTIES	THIRD-PARTIES	85%	sponsored research arrangements with third parties
ORANY	ORANY	72%	nes, damages, administrative civil money penalties, and exclusion from participation in federal healthcare programs. • The federal civil False Claims Act, which prohibits anyone from, among other thi…
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from DFTX graph: nes, damages, administrative civil money penalties, and exclusion from participation in federal healthcare programs.…
TNXP	Tonix Pharmaceuticals Holding Corp.	72%	Reciprocal relationship from TNXP graph: arket strategy. Our commercialization strategy for TONMYA is centered on a cost-efficient, targeted sales and marketing approach focused on the top prescribin…
XRTX	XORTX Therapeutics Inc.	62%	Reciprocal relationship from XRTX graph: Reciprocal relationship from DFTX graph: Reciprocal relationship from XRTX graph: Reciprocal relationship from DFTX graph: Reciprocal relationship from XRTX g…

Definium Therapeutics, Inc. Customers

Ticker	Name	Confidence	Evidence
ORANY	ORANY	72%	Reciprocal relationship from ORANY graph: Reciprocal relationship from DFTX graph: Reciprocal relationship from ORANY graph: Reciprocal relationship from DFTX graph: Reciprocal relationship from ORAN…
ORANY	ORANY	72%	nes, damages, administrative civil money penalties, and exclusion from participation in federal healthcare programs. • The federal civil False Claims Act, which prohibits anyone from, among other thi…
TNXP	Tonix Pharmaceuticals Holding Corp.	72%	Reciprocal relationship from TNXP graph: Reciprocal relationship from DFTX graph: Reciprocal relationship from TNXP graph: Reciprocal relationship from DFTX graph: Reciprocal relationship from TNXP g…
BROADWAY-GOLD-MINING-LTD	BROADWAY-GOLD-MINING-LTD	62%	, damages, administrative civil money penalties, and exclusion from participation in federal healthcare programs. • The federal civil False Claims Act, which prohibits anyone from, among other things…
EMERGING-GROWTH-COMPANY	EMERGING-GROWTH-COMPANY	62%	ommercialize any product candidates for which we may obtain marketing approval and intend to commercialize on our own or jointly; and • expand our operational, financial and management systems and in…
MADISON-METALS-INC-BROADWAY-DELAWARE-SUBCO-INC	MADISON-METALS-INC-BROADWAY-DELAWARE-SUBCO-INC	62%	, damages, administrative civil money penalties, and exclusion from participation in federal healthcare programs. • The federal civil False Claims Act, which prohibits anyone from, among other things…
MIND-MEDICINE-INC	MIND-MEDICINE-INC	62%	, damages, administrative civil money penalties, and exclusion from participation in federal healthcare programs. • The federal civil False Claims Act, which prohibits anyone from, among other things…

Definium Therapeutics, Inc. Debt Obligations

Instrument	Description	Confidence	Evidence
DFTX-DEBT	Debt stack $36.5M	90%	Market cache reports total debt of $36.5M.
DFTX-DEBT-9066	Warrants outstanding: 3767000	90%	xbrl warrant detail from xbrl 2025-12-31.

Definium Therapeutics, Inc. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Definium Therapeutics, Inc..

Definium Therapeutics, Inc. Ownership

Holder	Name	Confidence	Evidence
DFTX-OWNER-AVORO-CAPITAL-ADVISORS-LLC	Avoro Capital Advisors LLC	90%	13F overlay lists Avoro Capital Advisors LLC as top holder; 12 tracked holders.

Definium Therapeutics, Inc. Extended Supply Chain Network

Ticker	Name	Chain Index	Hops	Relationship Types
AXSM	Axsome Therapeutics, Inc.	100.00	2
JNJ	Johnson & Johnson	100.00	2
XRTX	XORTX Therapeutics Inc.	100.00	1	['supplier']
AZN	AstraZeneca PLC	100.00	2
ORANY	ORANGE	100.00	1	['customer', 'supplier']
TNXP	Tonix Pharmaceuticals Holding Corp.	100.00	1	['customer', 'supplier']
DWTX	Dogwood Therapeutics, Inc.	100.00	2
BFRGW	BullFrog AI Holdings, Inc.	50.00	2
ASBPW	Aspire Biopharma Holdings, Inc.	50.00	2
BCDRF	Banco Santander, S.A.	50.00	2
ARQQW	Arqit Quantum Inc.	50.00	2
AYTU	Aytu BioPharma, Inc.	50.00	2
CYCN	Cyclerion Therapeutics, Inc.	50.00	2
CMCM	Cheetah Mobile Inc.	50.00	2
CPRX	Catalyst Pharmaceuticals, Inc.	50.00	2
AMZE	Amaze Holdings, Inc.	50.00	2
BLTE	Belite Bio, Inc	50.00	2
DARE	Daré Bioscience, Inc.	50.00	2
EPDU	ENTERPRISE PRODUCTS PARTNERS L.P.	50.00	2
CINGW	Cingulate Inc.	50.00	2

Definium Therapeutics, Inc. Supply Chain